52
https://pubmed.ncbi.nlm.nih.gov/38116204
The review discusses how the protein c-Myc, which is often dysregulated in over 70% of human cancers, is also involved in obesity and associated metabolic dysfunctions, suggesting its potential as a diagnostic tool or therapeutic target for obesity.
